⌕
First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund · FFR · Nasdaq
Tenet 26 · Weak
Compare
$0.41−0.63%At closeTenet 26 · Weak
$0.410.00 (−0.63%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD

First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund (FFR) Stock

First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund (FFR) closed at $0.41 on Nov 19, 2026; its Tenet Score is 26 of 100 against 474 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Close
$0.41
Nov 19, 2026
Market cap
$24.7M
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
0.40 – 3.34
low → high
Tenet Score
26/100
Weak · 474 Healthcare peers

Industry: Drugs · see every company filed here →

First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund scores 26/100. Weak. Value is the soft spot versus 474 Healthcare peers. Insufficient inputs: Tenet 26 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=474
26/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
7
Quality
11
Health
60
Growth
—

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Growth omitted — no data yet.
ValueFQualityFHealthCGrowth—MomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
22.7×
cap ÷ Sep 30, 2026 book value, Nov 18, 2026 close
P/S
—
no P/S on file
ROE
−1332%
TTM through Sep 30, 2026
Outside the range we rank; ranked at the edge of the range.
Operating margin
—
no operating margin on file
Net margin
—
Not reported in the company's filings for this period.
Current ratio
2.98
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancr…

Composite computed Nov 19, 2026 · peer basis: Healthcare (n=474) · every glimpse links to its full section with sources · not investment advice.

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund in?

First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund is in the Healthcare sector and the Drugs industry.

What is First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund's Tenet Score?

First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund's Tenet Score is 26 out of 100, ranked against 474 Healthcare peers as of Nov 19, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.